A Plus Biotechnology , Ltd. Profit Margin

As of the most recent data (March 2026), 6918.TWO shows a profit margin of 20.2%. That compares with 20.15% in the prior-year period — up 0.2% year over year. That is above the sector sector average of 13.2%. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 6918.TWO's profit margin is now 20.2% (was 20.15%) — a 0.2% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether A Plus Biotechnology , Ltd. is outperforming or lagging.

The its sector sector average profit margin is about 13.2%. A Plus Biotechnology , Ltd. is at 20.2%, which is higher that average. That is roughly 53.0% above the sector mean. Use the comparison chart on this page to see how 6918.TWO stacks up against individual peers as well.

That compares with 20.15% in the prior-year period — up 0.2% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare A Plus Biotechnology , Ltd. with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has A Plus Biotechnology , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently 20.2%) with ownership activity and broader fundamentals.